[1]
J. E. Ordóñez and A. U. Palacios, “Cost-effectiveness analysis of Apixaban versus Enoxaparin in patients undergoing total hip or knee replacement in Colombia”, Rev. Colomb. Ortop. Traumatol., vol. 30, no. 4, pp. 133–140, Dec. 2016.